Optimization of the doxycycline-dependent simian immunodeficiency virus through in vitro evolution

Retrovirology

Volumn 5, Issue , 2008, Pages

  Das, Atze T ^a   Klaver, Bep ^a   Centlivre, Mireille ^a   Harwig, Alex ^a   Ooms, Marcel ^a   Page, Mark ^b   Almond, Neil ^b   Yuan, Fang ^c   Piatak Jr , Mike ^c   Lifson, Jeffrey D ^c   Berkhout, Ben ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^c SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; LIVE VACCINE; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; MACACA; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROMOTER REGION; RNA STRUCTURE; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSCRIPTION REGULATION; VIRUS INACTIVATION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; ANIMAL; CELL CULTURE; CELL LINE; CHEMICAL STRUCTURE; CONFORMATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; MOLECULAR EVOLUTION; MOLECULAR GENETICS; MONONUCLEAR CELL; SEQUENCE ALIGNMENT; VIROLOGY; VIRUS CULTURE; VIRUS GENE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; BASE SEQUENCE; CELL LINE; CELLS, CULTURED; DOXYCYCLINE; EVOLUTION, MOLECULAR; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENES, VIRAL; HUMANS; LEUKOCYTES, MONONUCLEAR; MACACA; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; SAIDS VACCINES; SEQUENCE ALIGNMENT; SERIAL PASSAGE; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 48949118745     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-5-44     Document Type: Article

References (44)

1. Koff WC Johnson PR Watkins DI Burton DR Lifson JD Hasenkrug KJ McDermott AB Schultz A Zamb TJ Boyle R Desrosiers RC HIV vaccine design: Insights from live attenuated SIV vaccines Nat Immunol 2006, 7:19-23. 10.1038/ ni1296 16357854
2. Johnson RP Desrosiers RC Protective immunity induced by live attenuated simian immunodeficiency virus Curr Opin Immunol 1998, 10:436-443. 10.1016/S0952-7915(98)80118-0 9722920
3. Mills J Desrosiers R Rud E Almond N Live attenuated HIV vaccines: proposal for further research and development AIDS Res Hum Retroviruses 2000, 16:1453-1461. 10.1089/088922200750005976 11054258
4. Whitney JB Ruprecht RM Live attenuated HIV vaccines: Pitfalls and prospects Curr Opin Infect Dis 2004, 17:17-26. 10.1097/ 00001432-200402000-00004 15090885
5. Baba TW Jeong YS Penninck D Bronson R Greene MF Ruprecht RM Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques Science 1995, 267:1820-1825. 10.1126/science.7892606 7892606
6. Baba TW Liska V Khimani AH Ray NB Dailey PJ Penninck D Bronson R Greene MF McClure HM Martin LN Ruprecht RM Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques Nat Med 1999, 5:194-203. 10.1038/8859 9930868
7. Chakrabarti LA Metzner KJ Ivanovic T Cheng H Louis-Virelizier J Connor RI Cheng-Mayer C A truncated form of Nef selected during pathogenic reversion of simian immunodeficiency virus SIVmac239Deltanef increases viral replication J Virol 2003, 77:1245-1256. 140812 12502842 10.1128/ JVI.77.2.1245-1256.2003
8. Whatmore AM Cook N Hall GA Sharpe S Rud EW Cranage MP Repair and evolution of nef in vivo modulates simian immunodeficiency virus virulence J Virol 1995, 69:5117-5123. 189330 7609080
9. Churchill MJ Rhodes DI Learmont JC Sullivan JS Wesselingh SL Cooke IR Deacon NJ Gorry PR Longitudinal analysis of human immunodeficiency virus type 1 nef/long terminal repeat sequences in a cohort of long-term survivors infected from a single source J Virol 2006, 80:1047-1052. 1346882 16379007 10.1128/JVI.80.2.1047-1052.2006
10. Berkhout B Verhoef K van Wamel JLB Back B Genetic instability of live-attenuated HIV-1 vaccine strains J Virol 1999, 73:1138-1145. 103934 9882315
11. Verhoef K Marzio G Hillen W Bujard H Berkhout B Strict control of human immunodeficiency virus type 1 replication by a genetic switch: Tet for Tat J Virol 2001, 75:979-987. 113994 11134311 10.1128/ JVI.75.2.979-987.2001
12. Smith SM Khoroshev M Marx PA Orenstein J Jeang KT Constitutively dead, conditionally live HIV-1 genomes. Ex vivo implications for a live virus vaccine J Biol Chem 2001, 276:32184-32190. 10.1074/jbc.M101604200 11397795
13. Berkhout B Marzio G Verhoef K Control over HIV-1 replication by an antibiotic; a novel vaccination strategy with a drug-dependent virus Virus Res 2002, 82:103-108. 10.1016/S0168-1702(01)00399-9 11885936
14. Das AT Zhou X Vink M Klaver B Berkhout B Conditional live virus as a novel approach towards a safe live attenuated HIV vaccine Expert Rev Vaccines 2002, 1:293-301. 10.1586/14760584.1.3.293 12901570
15. Das AT Verhoef K Berkhout B A conditionally replicating virus as a novel approach toward an HIV vaccine Methods Enzymol 2004, 388:359-379. 15289083
16. Baron U Bujard H Tet repressor-based system for regulated gene expression in eukaryotic cells: Principles and advances Methods Enzymol 2000, 327:401-421. 11044999.
17. Marzio G Verhoef K Vink M Berkhout B In vitro evolution of a highly replicating, doxycycline-dependent HIV for applications in vaccine studies Proc Natl Acad Sci USA 2001, 98:6342-6347. 33470 11353837 10.1073/pnas.111031498
18. Marzio G Vink M Verhoef K de Ronde A Berkhout B Efficient human immunodeficiency virus replication requires a fine-tuned level of transcription J Virol 2002, 76:3084-3088. 135974 11861878 10.1128/ JVI.76.6.3084-3088.2002
19. Das AT Zhou X Vink M Klaver B Verhoef K Marzio G Berkhout B Viral evolution as a tool to improve the tetracycline-regulated gene expression system J Biol Chem 2004, 279:18776-18782. 10.1074/ jbc.M313895200 14761948
20. Zhou X Vink M Klaver B Verhoef K Marzio G Das AT Berkhout B The genetic stability of a conditional-live HIV-1 variant can be improved by mutations in the Tet-On regulatory system that restrain evolution J Biol Chem 2006, 281:17084-17091. 10.1074/jbc.M513400200 16627480
21. Zhou X Vink M Klaver B Berkhout B Das AT Optimization of the Tet-On system for regulated gene expression through viral evolution Gene Ther 2006, 13:1382-1390. 10.1038/sj.gt.3302780 16724096
22. Zhou X Vink M Berkhout B Das AT Modification of the Tet-On regulatory system prevents the conditional-live HIV-1 variant from losing doxycycline-control Retrovirology 2006, 3:82. 1637113 17094796 10.1186/ 1742-4690-3-82
23. Kiselyeva Y Ito Y Lima RG Grivel JC Das AT Berkhout B Margolis LB Depletion of CD4 T lymphocytes in human lymphoid tissue infected ex vivo with doxycycline-dependent HIV-1 Virol 2004, 328:1-6. 10.1016/ j.virol.2004.07.014 15380352
24. Das AT Baldwin CE Vink M Berkhout B Improving the safety of a conditional-live human immunodeficiency virus type 1 vaccine by controlling both gene expression and cell entry J Virol 2005, 79:3855-3858. 1075741 15731280 10.1128/JVI.79.6.3855-3858.2005
25. Das AT Klaver B Harwig A Vink M Ooms M Centlivre M Berkhout B Construction of a doxycycline-dependent simian immunodeficiency virus reveals a non-transcriptional function of Tat in viral replication J Virol 2007, 81:11159-11169. 2045552 17670816 10.1128/JVI.01354-07
26. Mathews DH Sabina J Zuker M Turner DH Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure J Mol Biol 1999, 288:911-940. 10.1006/jmbi.1999.2700 10329189
27. Zuker M Mfold web server for nucleic acid folding and hybridization prediction Nucleic Acids Res 2003, 31:3406-3415. 169194 12824337 10.1093/ nar/gkg595
28. Pachulska-Wieczorek K Purzycka KJ Adamiak RW New, extended hairpin form of the TAR-2 RNA domain points to the structural polymorphism at the 5′ end of the HIV-2 leader RNA Nucleic Acids Res 2006, 34:2984-2997. 1474061 16738137 10.1093/nar/gkl373
29. Berkhout B Jeang KT Detailed mutational analysis of TAR RNA: Critical spacing between the bulge and loop recognition domains Nucleic Acids Res 1991, 19:6169-6176. 329115 1956776 10.1093/nar/19.22.6169
30. Huthoff H Berkhout B Two alternating structures for the HIV-1 leader RNA RNA 2001, 7:143-157. 1370064 11214176 10.1017/S1355838201001881
31. Berkhout B Ooms M Beerens N Huthoff H Southern E Verhoef K In vitro evidence that the untranslated leader of the HIV-1 genome is an RNA checkpoint that regulates multiple functions through conformational changes J Biol Chem 2002, 277:19967-19975. 10.1074/jbc.M200950200 11896057
32. Ooms M Huthoff H Russell R Liang C Berkhout B A riboswitch regulates RNA dimerization and packaging in human immunodeficiency virus type 1 virions J Virol 2004, 78:10814-10819. 516375 15367648 10.1128/ JVI.78.19.10814-10819.2004
33. Abbink TEM Ooms M Haasnoot PCJ Berkhout B The HIV-1 leader RNA conformational switch regulates RNA dimerization but does not regulate mRNA translation Biochem 2005, 44;9058-9066. 10.1021/bi0502588
34. Das AT Harwig A Vrolijk MM Berkhout B The TAR hairpin of human immunodeficiency virus type-1 can be deleted when not required for Tat-mediated activation of transcription J Virol 2007, 81:7742-7748. 1933349 17494072 10.1128/JVI.00392-07
35. Vrolijk MM Ooms M Harwig A Das AT Berkhout B Destabilization of the TAR hairpin affects the structure and function of the HIV-1 leader RNA Nucleic Acids Res 2008 Advance Access published June 27 18586822
36. Regier DA Desrosiers RC The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus AIDS Res Hum Retroviruses 1990, 6:1221-1231. 2078405
37. Guan Y Whitney JB Diallo K Wainberg MA Leader sequences downstream of the primer binding site are important for efficient replication of simian immunodeficiency virus J Virol 2000, 74:8854-8860. 102079 10982327 10.1128/JVI.74.19.8854-8860.2000
38. Auersperg N Long-term cultivation of hypodiploid human tumor cells J Nat Cancer Inst 1964, 32:135-163. 14114965
39. Lusso P Cocchi F Balotta C Markham PD Louie A Farci P Pal R Gallo RC Reitz MS Jr. Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): Failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1 J Virol 1995, 69:3712-3720. 189087 7745720
40. Mills KH Barnard AL Williams M Page M Ling C Stott EJ Silvera P Taffs F Kingsman AS Adams SE Almond N Kitchin PA Jones WC Vaccine-induced CD4+ T cells against the simian immunodeficiency virus gag protein. Epitope specificity and relevance to protective immunity J Immunol 1991, 147:3560-3567. 1719081
41. Lifson JD Rossio JL Piatak M Jr. Parks T Li L Kiser R Coalter V Fisher B Flynn BM Czajak S Hirsch VM Reimann KA Schmitz JE Ghrayeb J Bischofberger N Nowak MA Desrosiers RC Wodarz D Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment J Virol 2001, 75:10187-10199. 114593 11581387 10.1128/ JVI.75.21.10187-10199.2001
42. Cline AN Bess JW Piatak M Jr. Lifson JD Highly sensitive SIV plasma viral load assay: Practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS J Med Primatol 2005, 34:303-312. 10.1111/j.1600-0684.2005.00128.x 16128925
43. Maudru T Peden KW Adaptation of the fluorogenic 5′-nuclease chemistry to a PCR-based reverse transcriptase assay Biotechn 1998, 25:972-975.
44. Ruijter JM Thygesen HH Schoneveld OJ Das AT Berkhout B Lamers WH Factor correction as a tool to eliminate between-session variation in replicate experiments: Application to molecular biology and retrovirology Retrovirology 2006, 3:1-8. 1360091 16398928 10.1186/1742-4690-3-2